-
Data continue to be generated related to the use of robotic surgery in gynecology. At the current time, what the future holds for this latest technology within our specialty is anyone's guess.
-
The authors analyzed data from the Women's Health Initiative (WHI) combined Estrogen/Progestin Trial to determine if new-onset breast tenderness (NOBT) was associated with the development of breast cancer.
-
In the last two months, there were four articles in the American Journal of Obstetrics & Gynecology and Obstetrics & Gynecology dealing with drugs that are commonly used in pregnancy and their possible contribution to adverse outcomes. One of these articles was particularly attention-getting.
-
In this issue: Two oral medications for relapsing-remitting MS in phase III development; antihypertensives find new uses; Ginkgo biloba does not prevent cognitive decline in elderly; and FDA Actions.
-
-
Lynch Syndrome (LS) is a familial colorectal cancer syndrome, which occurs as a result of autosomal dominant inheritance of DNA mismatch repair genes.
-
After pelvic floor reconstructive surgery, antibiotic prophylaxis with daily nitrofurantoin during postoperative catheterization does not decrease risk of urinary tract infection.
-
This review outlines steps that OB/GYNs can take to support their patients who desire to breastfeed.
-
A variety of methods and medications are available to treat nausea and vomiting in pregnancy one of the most common and often vexing problems for pregnant women.
-
Selective estrogen receptor modulators (SERMs) like tamoxifene and raloxifene are now well-established therapeutics, and new agents such as bazedoxifene and ospemifene have recently been introduced. These new agents have unique tissue-specific profiles that allow for a customization of therapeutic effect. In this review, the profiles of bazedoxifene and ospemifene will be compared and discussed relevant to their place in clinical practice.